Non-publication and delayed publication of randomized trials on vaccines: survey
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the extent of non-publication or delayed publication of registered randomized trials on vaccines, and to investigate potential determinants of delay to publication. DESIGN: Survey. DATA SOURCES: Trials registry websites, Scopus, PubMed, Google. STUDY SELECTION: Randomized controlled trials evaluating the safety or the efficacy or immunogenicity of human papillomavirus (HPV), pandemic A/H1N1 2009 influenza, and meningococcal, pneumococcal, and rotavirus vaccines that were registered in ClinicalTrials.gov, Current Controlled Trials, WHO International Clinical Trials Registry Platform, Clinical Study Register, or Indian, Australian-New Zealand, and Chinese trial registries in 2006-12. Electronic databases were searched up to February 2014 to identify published manuscripts containing trial results. These were reviewed and classified as positive, mixed, or negative. We also reviewed the results available in ClinicalTrials.gov. MAIN OUTCOME MEASURES: Publication status of trial results and time from completion to publication in peer reviewed journals. DATA SYNTHESIS: Cox proportional hazards regression was used to evaluate potential predictors of publication delay. RESULTS: We analysed 384 trials (85% sponsored by industry). Of 355 trials (404,758 participants) that were completed, 176 (n=151,379) had been published in peer reviewed journals. Another 42 trials (total sample 62,765) remained unpublished but reported results in ClinicalTrials.gov. The proportion of trials published 12, 24, 36, and 48 months after completion was 12%, 29%, 53%, and 73%, respectively. Including results posted in ClinicalTrials.gov, 48 months after study completion results were available for 82% of the trials and 90% of the participants. Delay to publication between non-industry and industry sponsored trials did not differ, but non-industry sponsored trials were 4.42-fold (P=0.008) more likely to report negative or mixed findings. Negative results were reported by only 2% of the published trials. CONCLUSIONS: Most vaccine trials are published eventually or the results posted in ClinicalTrials.gov, but delays to publication of several years are common. Actions should focus on the timely dissemination of data from vaccine trials to the public.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Global burden of childhood pneumonia and diarrhoea
Walker, C. L. F., Rudan, I., Liu, L., Nair, H., Theodoratou, E., Bhutta, Z. A., O'Brien, K. L., Campbell, H., & Black, R. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60222-6 · Cited by 2,356
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003081 · Cited by 1,546
Self-citationBiomedical research: increasing value, reducing waste.
Macleod, M. R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J. P. A., Salman, R. A.-S., Chan, A.-W., & Glasziou, P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62329-6 · Cited by 1,003
Self-citationPublication bias in clinical trials due to statistical significance or direction of trial results
Hopewell, S., Loudon, K., Clarke, M. J., Oxman, A. D., & Dickersin, K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000006.pub3 · Cited by 898
Increasing value and reducing waste: addressing inaccessible research
Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., Krumholz, H. M., Ghersi, D., & van der Worp, H. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62296-5 · Cited by 887
Publication bias: evidence of delayed publication in a cohort study of clinical research projects
Stern, J. M., & Simes, R. J. (1997) · BMJ · doi:10.1136/bmj.315.7109.640 · Cited by 818
Understanding controlled trials: Why are randomised controlled trials important?
Sibbald, B., & Roland, M. (1998) · BMJ · doi:10.1136/bmj.316.7126.201 · Cited by 807
Ioannidis, J. P. A. (1998) · JAMA · doi:10.1001/jama.279.4.281 · Cited by 632
Self-citationOutcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
Chan, A.-W. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041086 · Cited by 444
Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
Ross, J. S., Mulvey, G. K., Hines, E. M., Nissen, S. E., & Krumholz, H. M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000144 · Cited by 401
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
Ross, J. S., Tse, T., Zarin, D. A., Xu, H., Zhou, L., & Krumholz, H. M. (2012) · BMJ · doi:10.1136/bmj.d7292 · Cited by 371 · cited 1×
“6 When numerous intervention formulations are typically developed, it is not easy to extrapolate inferences from one formulation to another given the missing data.(2) 31 Also, there is a substantial literature in various specialties that trials with non-significant, less favorable, or even “negative” results are more…”
ResultNon-publication of large randomized clinical trials: cross sectional analysis
Jones, C. W., Handler, L., Crowell, K. E., Keil, L. G., Weaver, M. A., & Platts-Mills, T. F. (2013) · BMJ · doi:10.1136/bmj.f6104 · Cited by 350
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00006 · Cited by 332
Rising, K., Bacchetti, P., & Bero, L. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050217 · Cited by 328 · cited 4×
“However, as discussed, given the efforts to identify publications, any missed papers are unlikely to be identified during routine or even systematic searches.(10) Secondly, it is possible that some additional trials were not registered.”
BackgroundMethodInfluentialManuscript Quality before and after Peer Review and Editing at Annals of Internal Medicine
Goodman, S. N., Berlin, J., Fletcher, S. W., & Fletcher, R. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00003 · Cited by 324
Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I., & Ravaud, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001566 · Cited by 269
Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
Lee, K., Bacchetti, P., & Sim, I. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050191 · Cited by 215 · cited 3×
“com.(8) 10 13-20 The publication rate was lower than 60% in 30 out of 41 surveys, and a rate higher than 80% was reported only by three studies, which were based on selected samples of randomized controlled trials funded by the US National Institutes of Health,(21) by the UK National Institute for Health Research Heal…”
BackgroundMethodInfluentialStatistical Reviewers Improve Reporting in Biomedical Articles: A Randomized Trial
Cobo, E., Selva-O'Callagham, A., Ribera, J.-M., Cardellach, F., Dominguez, R., & Vilardell, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000332 · Cited by 112
Trial Registration Numbers Are Underreported in Biomedical Publications
van de Wetering, F. T., Scholten, R. J. P. M., Haring, T., Clarke, M., & Hooft, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049599 · Cited by 79 · cited 1×
“Unpublished trials produce no scientific and social benefits, and their expenses, often large, are wasted.(13) 14 29 30 We suggest that the rationale for the publication of trial results should be extended to enforce not only publication but also timely publication or registration of these valuable results.”
BackgroundCompleteness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas
Ioannidis, J. P. A., & Lau, J. (2001) · JAMA · doi:10.1001/jama.285.4.437 · Cited by 3
Self-citation
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Flacco, M. E., Manzoli, L., Boccia, S., Capasso, L., Aleksovska, K., Rosso, A., Scaioli, G., De Vito, C., Siliquini, R., Villari, P., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.016 · Cited by 177
Self-citationMoorthy, V. S., Karam, G., Vannice, K. S., & Kieny, M.-P. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001819 · Cited by 155
“Among randomised clinical trials (RCTs) of vaccines against five diseases registered in a variety of databases between 2006–2012, only 29% had been published in a peer-reviewed journal by 24 months following study completion [4].”
BackgroundMellor, K., Albury, C., Dutton, S. J., Eldridge, S., & Hopewell, S. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01291-5 · Cited by 145
Bashir, R., Bourgeois, F. T., & Dunn, A. G. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0518-3 · Cited by 47
Metadata
- Authors
- Manzoli, L., Flacco, M. E., D'Addario, M., Capasso, L., De Vito, C., Marzuillo, C., Villari, P., & Ioannidis, J. P. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-05-16
- Volume
- 348
- Issue
- may16 1
- Pages
- g3058-g3058
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2163042043
- Cited by
- 99
- References
- 22
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.